Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (11567)	11/21/1997 3:13:00 PM
From: Flagrante Delictu	Read Replies (1) \| Respond to of 32384

Andy>> The chances of a major publication cancelling an article because someone on SI speculated on it are about the same as you discontinuing your offensive sense of humor<< If I read the tea leaves correctly, I note a personal attack in this and prior posts rather than an answer to the question of where you got the information that LGND stated at the OPCO conference that there would be an announcement in 2 weeks that LGND had selected a Lilly compound. Since you told us that you told Susan Atkins that such information had come from the conference, I'm sure that she as well as I would be interested in your source for this information. , >> take responsibility for your own errors in reporting and try not to blame them on me.<< I'm sure you will be kind enough to enumerate the specific errors in reporting that I have made and also the ones I am trying to blame on you. P.S. I haven't noticed in this response whether you're interested in the wine bet. Best regards, Bernie.